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Home-based exercise is capable of preserving
hospital-based improvements in severe chronic
obstructive pulmonary disease*
M. BEHNKE, C. TAUBE, D. KIRSTEN, B. LEHNIGK, R. A. JO¨RRES AND H. MAGNUSSEN
Krankenhaus Grosshansdorf, Zentrum fu¨r Pneumologie und Thoraxchirurgie, D-22927 Grosshansdorf, Germany
We examined the feasibility of home-based walking training to maintain the benefits of a short-term exercise
training in patients with severe chronic obstructive pulmonary disease (COPD).
After initial recovery from an exacerbation, 46 patients were randomized into a training and a control group, and
30 patients completed the programme (mean+ SD FEV1, 36+ 7 % predicted). The training group performed a 10-
day walking training programme in the hospital, followed by a 6-month programme of supervised walking training
at home, integrated into daily activities. The control group did not have exercise training in the hospital or at home.
Until 6 months after discharge, lung function, exercise performance and symptom scores were assessed.
Six-minute walking distance in the training group improved from day 1 to day 10 (P50?001) and this effect was
maintained over 6 months (P50?001). On average, daily walking distance at home was 2308m and walking was
reported on 157 days. Quality of life (QoL) scores changed significantly over 6 months (P50?001). The control
group showed no significant changes in exercise performance or QoL scores throughout the whole study period.
Therefore, (i) significant improvements in exercise performance and Chronic Respiratory Disease Questionnaire
(CRQ) scores could be achieved after recovery from an exacerbation and (ii) these improvements were maintained
after discharge, when supported by a home-based walking training.
Key words: exercise therapy; lung diseases; obstructive; home care; walking; exercise performance; quality of life;
dyspnoea.
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Exercise is an essential component of pulmonary rehabili-
tation in patients with chronic obstructive pulmonary
disease (COPD) (1,2). However, its role after exacerbations
of respiratory diseases is not clear (2), although patients
may benefit from a short-term training programme (3).
As the transient nature of training effects is well known
(4), several studies have evaluated whether the benefits of
rehabilitation programmes can be maintained by home-
based exercise or rehabilitation (5–7). The long-term effects
of such programmes showed considerable variation, parti-
cularly regarding exercise tolerance and quality of life
(QoL), possibly due to differences in methodology or
patient characteristics (5–7).*This study is part of the doctoral thesis of M. Behnke.
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which require the ability to walk, pulmonary exercise
programmes should include lower extremity training (1). It
is known that walking or stair-climbing can lead to
significant improvements in exercise tolerance and QoL if
performed over several weeks (6), in accordance with the
assumption that benefits are primarily achieved in those
activities that are trained (8).
Starting from these premises, we investigated patients
with severe COPD, who performed a 10-day hospital-based
walking training programme after initial recovery from an
exacerbation and assessed whether the improvements
achieved during this period could be maintained after
discharge by home-based walking integrated into daily
activities. A group of patients without exercise in the
hospital or at home served as a control to assess potential
long-term trends in the patients’ clinical condition.
Methods
PATIENTS
We included patients with severe COPD according to
international guidelines (9), who were admitted to the# 2000 HARCOURT PUBLISHERS LTD
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study was started 4–7 days after admission, when the
patients’ condition had stabilized. Exclusion criteria were:
evidence of unstable cardiac disease, cor pulmonale decom-
pensation or other disabling diseases which prevented
participation in the exercise programme, such as orthopae-
dic inabilities or peripheral vascular disease. Twenty-four of
the patients were on oral theophylline and systemic
corticosteroids. Medication was continued throughout the
training period and did not differ between the two groups.
The study was approved by the appropriate ethical
committee and written informed consent was obtained from
each patient. Thirty out of 46 patients completed the
protocol; their characteristics are given in Table 1.
STUDY DESIGN
Forty-six patients were recruited and randomly allocated to
a training or a control group. Patients in the training group
started training when they were stable enough to meet the
demands of physical exercise, whereas patients of the
control group did not receive a structured training
programme. Both groups were supervised by the coordinat-
ing physician (M.B.).
Hospital-based training period
All patients underwent baseline testing on day 0, including
assessment of lung function, overall dyspnoea and qualityTABLE 1. Baseline characteristics
Training group
(n=15)
Control group
(n=15)
Gender m/f 12/3 11/4
Age years 64?0+ 1?9 68?0+ 2?2
BMI kg/m2 24?6+ 1?1 24?4+ 1?0
FVC % predicted 72?0+ 3?8 73?5+ 3?4
FEV1 % predicted 34?1+ 7?4 37?5+ 6?6
TLC % predicted 125?6+ 24?3 122?8+ 16?3
RV % predicted 218?7+ 16?1 206?2+ 11?8
ITGV % predicted 185?5+ 44?9 188?3+ 32?2
DLCO % 56?3+ 22?2 51?3+ 21?3
PaO2 torr 63?5+ 8?7 63?9+ 6?9
PaCO2 torr 40?5+ 5?2 41?9+ 7?5
Borg at rest Score 2?4+ 0?3 2?7+ 0?4
BDI Score 3?9+ 0?6 3?8+ 0?4
CRQ Score 79?3+ 5?3 79?5+ 5?0
Values are given as mean+SD to indicate the within-subject
variation at inclusion.
Abbreviations: BMI : body mass index; ITGV : intra-thor-
acic gas volume; DLCO : diffusing capacity for carbon
monoxide; BDI : Baseline Dyspnoea Index; CRQ :Chronic
Respiratory Disease Questionnaire.
Predicted values were calculated according to ERS guide-
lines (11).of life (3) and two self-paced 6-min treadmill walking tests
to become familiar with the procedure (10). Exercise
performance was quantified on days 1 and 10 by the 6-
min treadmill distance. Additionally, on day 11 patients
performed a 6-min treadmill test at the same speed as on
day 1 and all measurements done at day 0 were repeated.
The 10-day training comprised a daily 6-min treadmill
test and five self-controlled walking sessions on the
corridor, where patients were instructed to achieve at least
75% of the treadmill walking distance of the respective day.
Both groups had identical conventional therapy, including
pharmacological therapy and 30 min daily breathing
exercises (diaphragmatic and pursed lips breathing).
Home-based training period
The home-based training period covered 6 months. At the
time of discharge, patients of the training group received an
individually tailored instruction to practice walking at
home (three times per day at 125% of the best 6-min
treadmill distance within 15 min). This approach was
chosen to facilitate the integration of walking into daily
activities, e.g. going shopping or taking a regular walk.
Control patients were only advised to perform exercise but
without specific instructions. All patients maintained their
standard medical treatment and documented medication
and GP visits. Training patients used diaries collected
monthly by post to record walking distances and the time
spent on walking. During the first 3 months each training
patient was visited every 2 weeks by one of the investigators
(M.B.) to check health status. Afterwards, contact was
maintained by monthly phone calls.
In all patients, lung function, maximal exercise perfor-
mance by 6-min treadmill test and symptom scores were
assessed in the hospital 1, 2, 3 and 6 months after discharge.
On these occasions, the current state of health was also
determined and patients’ diaries were checked. An addi-
tional 6-min treadmill test at the identical speed as on day 1
of the hospital-based training was done on the visit 6
months after discharge, 2 h after the first test.
LUNG FUNCTION TESTING AND BLOOD
GAS ANALYSIS
At baseline (day 0) and on day 11, total lung capacity
(TLC), intra-thoracic gas volume (ITGV), residual volume
(RV), FEV1, forced vital capacity (FVC) (Masterlab, Jaeger,
Wu¨rzburg, Germany) and the transfer factor for carbon
monoxide (DLCO) were assessed. Lung function tests were
repeated at the 1-, 2-, 3- and 6-month visits; predicted values
were taken from ERS guidelines (11). In addition, blood gas
analysis was performed using arterialized capillary samples
from the hyperaemic ear lobe to obtain PaCO2 and PaO2
(Model 278, Ciba Corning, Fernwald, Germany).
DYSPNOEA SCORES
Dyspnoea was quantified using the Baseline/Transitional
Dyspnoea Index (BDI/TDI) (12). Ratings for each category
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of task) were determined and a baseline focal score ranging
from 0 to 12 was calculated by adding the three category
scores, with lower scores indicating greater impairment.
The TDI which measures changes from the BDI involved
category scores from +3 (major improvement) to 73
(major deterioration). Again, the scores of all three
categories were summed up to give a focal transition score
(range +9 to 79).
All patients rated their dyspnoea at rest according to the
modified categorical Borg Scale (13) on days 0 and 11 and
at every visit after discharge.
QUALITY OF LIFE SCORES
Quality of life (QoL) was assessed using the Chronic
Respiratory Disease Questionnaire (CRQ) (14,15). Physical
function was quantified by the five items relating to the
dimension ‘dyspnoea’ and by the four items relating to the
dimension ‘fatigue’. Assessment of emotional function,
corresponding to the dimensions ‘emotion’ and ‘mastery’,
was based on the questions about frustration, depression,
anxiety, panic and fear of dyspnoea. Patients were asked to
rate their physical and emotional function on a seven-point
scale, with a higher score representing better function. The
scores of the four dimensions were added to obtain an
overall QoL score. At baseline as well as 3 and 6 months
after discharge, the questionnaire was administered as a
structured interview, and all interviews were performed by
the same investigator (M.B.).
EXERCISE PERFORMANCE
Exercise performance was assessed as the 6-min walking
distance (6MWD) in a self-paced treadmill walking test
(16) on a horizontal treadmill (LE 2000, Jaeger). The
treadmill was equipped with a speed control module for the
patient’s use. Patients were instructed to walk as far as
possible in 6 min; no further encouragement was given
during the walk; however, arm support was allowed. At the
beginning and end of each test, patients indicated the level
of dyspnoea on the modified Borg Scale. Heart rate (HR)
and oxygen saturation were measured continuously by a
pulse oximeter from the ear lobe (Nellcor Symphony 300).
Systolic and diastolic blood pressures were measured before
and every 2 min during the treadmill test. For analysis,
mean values over the 6-min walking periods were taken.
Venous blood samples were drawn immediately prior to
each treadmill test and within the last minute of exercise.
Aliquots (20ml) of each sample were mixed with iced
perchlorate solution (200 ml), centrifuged, and the super-
natant was analysed for lactic acid concentration (17). At
the same time points, blood gases were measured from the
hyperaemic ear lobe.
DATA ANALYSIS
Parametric tests were used for parameters which were
normally distributed and non-parametric tests for the otherparameters. For lung function, blood gas, exercise para-
meters and Borg scale, arithmetic mean values and
standard deviations of mean (SEM) were computed. Values
obtained in the training and control group were compared
by the unpaired t-test or the Mann–Whitney U-test.
ANOVA and paired t-tests or Wilcoxon matched-pairs
signed-ranks tests were employed to compare values
obtained on different study days. For correlation analysis,
Spearman’s rank correlations coecients were used. All
tests were performed two-tailed and the level of significance
was set at P=0?05. To limit the number of data presented,
values obtained only at the 1- and 2-month visits are
presented only in Fig. 1.
Results
Sixteen of the 46 patients failed to complete the
programme. In the training (control) group, one (one)
patient died, one (three) patients had an exacerbation, four
(two) patients dropped out due to lack of motivation and
two (two) patients due to unrelated diseases. Therefore, 30
patients were included in the final analysis. Baseline
characteristics did not differ significantly between groups
(Table 1).
TRAINING DISTANCES
The training group achieved a mean (+ SEM) daily distance
of 2930+479m (range 420–15000m) during the hospital-
based training. On each day, the mean daily distance
correlated significantly with the respective 6MWD (P50?05
each). According to the diaries, the mean (+ SEM) daily
distance during the 6 months training period was
2308+532m. On average, walking was reported on 157
(range 137–168) days.
EXERCISE PERFORMANCE
In the training group but not in the control group,
6MWD changed significantly over the study period
(ANOVA, P50?00001). Mean (+ SEM) values increased
from 265+26m on day 1 to 490+33m on day 10
(P50?001; Fig. 1), whereas the control group changed from
223+;17m on day 1 to 231+18m on day 10 (NS).
6-MWD differed significantly between groups on day 10
(P50?001). Furthermore, in the training group but not in
the control group, 6MWD at 3 and 6 months was
significantly greater than that achieved on day 1 (P50?001
each). At all of the follow-up visits, the difference between
both groups was statistically significant (P50?001 each).
RESPONSES TO IDENTICAL LEVELS OF
EXERCISE AS ON DAY 1
On day 11 as compared to day 1, heart rate (P50?001),
systolic blood pressure (P50?001), blood lactate (P=0?05)
and Borg score (P50?001) were significantly reduced in the
training group (Table 3; Fig. 1). Also, the control group
TABLE 2. Lung function data over six months
Baseline Day 11 Month 3 Month 6
Training group
FVC l 2?8+ 0?2 3?2+ 0?2{ 3?1+ 0?2 3?0+ 0?1
FEV1 l 0?99+ 0?06 1?20+ 0?07
{ 1?16+ 0?08{ 1?22+ 0?11*
TLC l 8?0+ 0?4 7?7+ 0?3 7?6+ 0?4 7?6+ 0?3
RV l 5?2+ 0?3 4?5+ 0?2* 4?6+ 0?4 4?5+ 0?3*
ITGV l 6?4+ 0?4 6?0+ 0?3 6?2+ 0?4 5?8+ 0?4
Control group
FVC l 2?7+ 0?2 2?9+ 0?2 2?6+ 0?2 2?5+ 0?2}
FEV1 l 1?02+ 0?07 1?15+ 0?11 1?05+ 0?08 1?03+ 0?08
TLC l 7?6+ 0?4 7?4+ 0?4 7?3+ 0?3 7?1+ 0?4
RV l 4?9+ 0?3 4?5+ 0?3* 4?7+ 0?3 4?5+ 0?3
ITGV l 6?3+ 0?4 5?9+ 0?4 5?9+ 0?3 5?8+ 0?4
Values are mean+ SEM. Significantly different from baseline at* P0?05;{P50?01; {P50?001.
Significantly different versus training group }P50?05.
Fig. 1. Changes in outcome parameters in the training (————) and control (- - - - - - ) patients during hospital- and home-
based walking training. (a) Changes in 6-min walking distance, indicating significant maintenance of exercise performance
within the training group. (b) Changes in Chronic Respiratory Disease Questionnaire (CRQ) scores, showing an ongoing
improvement of quality of life in the training group. (c) Changes in overall dyspnoea, measured by the Transitional
Dyspnoea Index (TDI) focal scores, demonstrating sustained reduction within the training group. Data are shown as
mean+ SEM. *P50?05, **P50?01, ***P50?001 versus baseline.
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score. Furthermore, at 6 months as compared to day 1,
exercise parameters remained significantly improved in the
training group, in terms of heart rate (P50?01), systolicblood pressure (P50?001), blood lactate (P50?05) and
Borg score (P50?01) (Table 3, Fig. 1); the control group
did not improve. Within the two groups, the values at day
11 and at 6 months did not differ.
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In both groups, TDI focal score changed significantly over
the study period (ANOVA, P50?002, each). Specifically,
there were significant improvements in the training group
(þ6?9+0?6, P50?001) as well as the control group
(þ3?1+0?8, P50?01; Fig. 1) on day 11; differences between
groups were also significant (P50?001). After 3 and 6
months, scores were positive in the training group
(þ4?6+0?7 and þ4?4+0?8, respectively; P50?001 each),
whereas in the control group scores were near 0 at 3 months
(NS) and negative (P50?05) at 6 months [þ0?3+0?9 and
72?8+1?1; Fig. 1(c)]. Differences between both groups
were also significant at both visits (P50?001 each).
QUALITY OF LIFE
CRQ sum scores showed significant changes in the training
group (ANOVA, P50?0001) but not in the control group.
Specifically, there were improvements after 3 and 6 months
(P50?01, each; Fig. 1). Also, differences between groupsTABLE. 3 Exercise parameters at identical work-load
Training group
Day 1 Day 11 M
6MWD m 265?3+ 26?7 = day 1
Borg scale 3?1+ 0?4 1?1+ 0?3{
Systolic BP torr 165?7+ 2?3 140?7+ 3?5{ 14
Diastolic BP torr 78?3+ 1?5 74?4+ 2?3 7
Heart rate min71 116?7+ 3?5 102?1+ 2?3{ 10
PaO2 torr 60?7+ 3?0 65?2+ 2?2 6
PaCO2 torr 39?0+ 1?7 38?3+ 1?4 3
Lactate mmol l71 3?41+ 0?40 2?41+ 0?20* 2
*Values are mean+ SEM.
Abbreviations: 6MWD : 6-min walking distance; BP : bloo
{P50?01; {P0?001.
Significantly different vs. training group }P50?05; }P50?01; **
TABLE 4. Quality of life data over 6 months
Training group
CRQ-component Baseline Month 3 Mon
Dyspnoea 13?2+ 1?1 22?1+ 1?4{ 25?3
Fatigue 17?0+ 1?5 20?7+ 1?1* 23?5
Emotion 31?5+ 2?6 38?8+ 2?1{ 42?1
Mastery 17?7+ 1?3 23?5+ 1?2{ 25?9
Values are mean+ SEM.
Abbreviations: CRQ :Chronic Respiratory Disease Questionnai
{P50?001.
Significantly different vs. training group at }P50?05, }P50?01;reached statistical significance at 3 and 6 months (P=0?01
each). The training group showed higher scores in all
dimensions of the CRQ 6 months after discharge (P50?01
each), as compared to day 1. In the control group, the
dimension ‘dyspnoea’ showed a clinically (18), although not
statistically significant, change by þ2?6 points after 3
months (Table 4); at 6 months, however, there were neither
clinically nor statistically significant changes in any of the
four dimensions.
LUNG FUNCTION
On day 11 as compared to day 0, the training group showed
a significant increase in FEV1 and VC (P50?01 each), and
a reduction in RV (P50?05) (Table 2). In the control
group, there was a significant decrease in RV (P50?05).
After 3 and 6 months as compared to day 0, FEV1 was
significantly increased in the training group (P50?05 each)
and RV showed a significant decrease (P=0?05) after 6
months (Table 2). There were no significant changes in the
control group.Control group
onth 6 Day 1 Day 11 Month 6
= day 1 222?9+ 16?8 = day 1 = day 1
1?6+ 0?4{ 3?7+ 0?3 2?6+ 0?3** 3?7+ 0?5}
6?7+ 4?0{ 157?7+ 5?1 152?3+ 5?5 156?3+ 4?4}
6?0+ 1?6 76?3+ 2?2 73?3+ 2?2 75?0+ 2?6
3?7+ 2?2{ 119?1+ 2?8 116?1+ 4?1} 116?9+ 3?4}
6?2+ 3?1 61?0+ 2?7 60?2+ 2?4 59?3+ 2?4
8?7+ 1?7 39?8+ 1?5 38?7+ 1?0 38?2+ 1?3
?18+ 0?22* 2?61+ 0?19 2?34+ 0?16 2?35+ 0?21
d pressure. Significantly different from baseline *P0?05;
P50?001.
Control group
th 6 Baseline Month 3 Month 6
+ 1?6{ 13?1+ 1?0 15?7+ 1?6} 13?9+ 1?7**
+ 0?8{ 15?3+ 1?4 15?7+ 1?2} 14?5+ 1?5**
+ 1?7{ 33?1+ 2?4 33?7+ 2?2 31?9+ 2?5}
+ 0?6{ 17?9+ 1?5 18?9+ 1?2} 17?5+ 1?5**
re. Significantly different from baseline at *P0?05; {P50?01;
**P50?001.
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Correlation analyses were performed over the whole study
population, and correlation coecients values are given for
the 6-month visit. Changes in 6MWD were significantly
(P50?001, each) correlated with TDI focal score (r=0?82)
and changes in CRQ sum score (r=0?65). Changes in FEV1
(r=0?55) and VC (r=0?42) were correlated (P50?05 each)
with changes in CRQ sum scores as well as with TDI focal
scores and changes in 6 MWD (P50?05 each). TDI focal
scores also showed significant a correlation with changes in
quality of life scores (r=0?77; P50?001).
Discussion
This study demonstrates that the improvements in exercise
performance, dyspnoea and QoL achieved through a
hospital-based exercise training programme in patients
with severe COPD, could be maintained after discharge
over a period of 6 months. Patients performed a home-
based regular exercise programme that was integrated into
their daily life. In contrast, patients without exercise
showed only minor improvements in dyspnoea and lung
function after the 10-day hospital treatment, which failed to
be maintained over 6 months. The fact that functional
parameters were fairly stable in these patients suggested
that the improvements observed in the training group were
not due to the further recovery from the exacerbation and
that there was a sucient time interval between exacerba-
tion and inclusion.
It is already known that exercise training per se improves
exercise performance (6) and that a short period of exercise
after initial recovery from an acute exacerbation also
significantly improves exercise performance, dyspnoea rat-
ings and lung function (3). In the present study, 6MWD
increased by about 75% during the hospital-based training.
This value is higher than those reported before in stable
COPD, where increases in 12- or 6-min walking distance
reached at maximum 33% (6,19,20). The difference is not
likely to be due to recovery, since the control group did not
show significant changes in 6MWD. In contrast, it might
have been due to the use of different methodologies, as the
treadmill walking test used by us allowed for arm support
and thereby could have led to larger increases in walking
distance than free walking. On the other hand, it is known
that treadmill distances may also be smaller than those
achieved by free walking (21). In either case, the reprodu-
cibility of treadmill and free walking appears to be similar.
The increases in exercise performance after hospital-
based training were accompanied by reductions in blood
lactate and heart rate (29 and 15%, respectively) for a given
treadmill speed. These parameters have been described as
sensitive markers of conditioning in patients with COPD
undergoing pulmonary rehabilitation (22). Studies which
evaluated near-high intense training in patients with severe
COPD achieved reductions in blood lactate at iso-exercise
between 14 and 38% (23,24). We therefore infer that
exercise during the hospital-based part of our study was
intense enough to produce physiological effects.Physiological benefits of exercise training are transient
when exercise is not continued on a regular basis (4).
Therefore, we did not include a group with exercise in the
hospital but not at home. Instead, the group receiving
training in the hospital also performed the home-based
walking programme. The control group served to assess
long-term improvements that would have occurred without
supervised training.
Several strategies to maintain the benefits of a preceding
intensive core training programme have been studied (5–7,
25). Studies which investigated the effects of exercise at
home showed variable results, probably owing to different
patients’ characteristics, training modalities or supervision
(5,6,25). The home-based training used in our study was
level walking, since we hypothesized that the basic
requirement for managing daily life, i.e. being able to walk,
should be the core of the training and that the hospital-
based training, as the first step, should focus on the training
of specific muscle groups of the lower extremity (8).
Training patients maintained exercise performance over 6
months and the level of blood lactate at a given treadmill
speed showed an even further decline as compared to
discharge from the hospital. This finding suggests progres-
sive adaptation to exercise and therefore continuously
increasing effects which were, however, not reflected in any
further increase in walking distance over the values
achieved in the hospital. In fact, inspection of Fig. 1(a)
suggests that towards the end of the 10-day training period
plateau values of walking distance were approached. It
might be speculated that the maximum distance achievable
was given by peripheral muscle eciency as well the
limitation in respiratory function as individual determi-
nants.
A number of patients (n=10) were followed up for a
longer period of time, and the improvements in exercise
performance were maintained over up to 18 months (data
not shown). Also, other studies have already demonstrated
that walking at home supported the maintainance of
training effects over several months (6,25), possibly because
patients became used to regular walking (26).
Dyspnoea is the most common complaint in patients with
COPD (2) and exercise training is capable of decreasing
dyspnoea by reduction of ventilatory demand and meta-
bolic load (27) as well as by desensitization (28). The short-
term training caused a 65% reduction in dyspnoea at
identical treadmill speed, similar to previous findings (3,
25). Dyspnoea was also decreased in the control group,
possibly owing to a reduction in hyperinflation (29) in
terms of residual volume. However, the benefits of the
hospital-based walking training could easily be recognized
by comparison between groups and the difference in
dyspnoea was similar to that reported in a previous study
(27). Improvements in exertional dyspnoea were main-
tained over at least 6 months of daily home exercise, in
accordance with a previous study (26), and overall
dyspnoea was associated with exercise performance
(6MWD), similar to previous findings (12,30). Our ob-
servations suggest that exercise at home may induce
desensitization to dyspnoea as well as increased self-
confidence and independence.
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assessed by TDI was significantly reduced, as previously
observed after exercise training (25,27) or comprehensive
pulmonary rehabilitation (31). However, the improvement
was reached in only 10 days. Regular exercise, even at a low
level (7), can lead to a persistent reduction in dyspnoea
(6,26), which diminishes as soon as training is stopped. In
comparison, the protocol used by us appeared to produce
relatively large effects. It may be speculated that our
approach of integrating the exercise into daily life has
increased the patients’ motivation.
The training group showed an ongoing increase in CRQ
score exceeding the minimal clinically important difference
(32). Values were also larger than those found after
comprehensive pulmonary rehabilitation (5,20,33). The
hospital treatment may have contributed to this, as indicated
by the slight improvement in the control group. The training
group showed an even further increase in QoL scores during
the home-based walking. Until now, positive effects over a
period as long as 6 months have only been reported after
comprehensive outpatient pulmonary rehabilitation (19).
Several factors may have contributed to our result: (i) during
the first 3 months, patients received regular medical care and
felt safe and were encouraged to continue the exercise;
(ii) additional home visits were included to improve the
patients’ compliance with the protocol; (iii) the long-term
training may have induced desensitization to dyspnoea
which in turn promoted the motivation for exercise; (4)
since the patients were able to carry out everyday activities
that they had avoided previously, they may have felt more
self-sucient, independent and again motivated to continue
the training. The correlations between the changes in
treadmill distance and CRQ sum scores, similar to literature
data (14), support these hypotheses.
Previous studies reported on an increase in VC and/or
FEV1 after training, which was thought to be due to a
reduction in air-trapping (3) or increased bronchodilator
effectiveness (34). In the present study, FEV1 was increased
and RV reduced after the hospital-based training. Probably,
the reduction in lung hyperinflation was the result of the
ongoing pharmacological treatment, since it also occurred in
the control group. This improvement was maintained over 6
months in the training group, but not in the control group.
It should be noted that patients were included after an
exarcerbation of their disease. The fact, however, that in the
control group values of 6MWD and lung function were
fairly constant from inclusion until 6 months, suggests that
the major functional impairment of the exacerbation had
already been overcome upon entry into the study.
In summary, our data demonstrate that the improve-
ments in exercise performance and symptom scores
achieved through a short-term hospital-based training in
patients with severe COPD after initial recovery from an
exacerbation, could be maintained after discharge over at
least 6 months. For this purpose, a home-based walking
training programme adapted to the needs and abilities of
the patients within their everyday life, turned out to be
feasible and effective. In the absence of a specific training
programme clinically significant improvements did not
occur.Acknowledgements
This study was supported by the Verein zur Fo¨rderung der
Rehabilitationsforschung in Schleswig-Holstein e.V.,
Deutsche Gesellschaft fu¨r Medizinische Rehabilitation
and Landesversicherungsanstalt Freie und Hansestadt
Hamburg, Germany.
References
1. ACCP/AACVPR Pulmonary Rehabilitation Guide-
lines Panel. Pulmonary Rehabilitation: joint ACCP/
AACVPR evidence-based guidelines. Chest 1997; 112:
1363–1396.
2. American Thoracic Society. Pulmonary Rehabilitation
— 1999. Am J Respir Crit Care Med 1999; 159: 1666–
1682.
3. Kirsten DK, Taube C, Lehnigk B, Jo¨rres RA,
Magnussen H. Exercise training improves recovery in
patients with COPD after an acute exacerbation. Respir
Med 1998; 92: 1191–1198.
4. American College of Sports Medicine. Position stand.
The recommended quantity and quality of exercise for
developing and maintaining cardiorespiratory and
muscular fitness in healthy adults. Med Sci Sports Ex
1990; 22: 265–274.
5. Wijkstra PJ, TenVergert EM, Van Altena R, Otten V,
Kraan J, Postma DS, Koeter GH. Long-term benefits
of rehabilitation at home on quality of life and exercise
tolerance in patients with chronic obstructive pulmon-
ary disease. Thorax 1995; 50: 824–828.
6. Cockcroft AE, Saunders MJ, Berry G. Randomised
controlled trial of rehabilitation in chronic respiratory
disability. Thorax 1981; 36: 200–203.
7. Ries AL, Kaplan RM, Limberg TM, Prewitt LM.
Effects of pulmonary rehabilitation on physiologic and
psychological outcomes in patients with chronic
obstructive pulmonary disease. Ann Intern Med 1995;
122: 823–832.
8. Lake FR, Henderson K, Briffa T, Openshaw J, Musk
AW. Upper-limb and lower-limb exercise training in
patients with chronic airflow obstruction. Chest 1990;
97: 1077–1082.
9. European Respiratory Society. ERS consensus state-
ment: Optimal assessment and management of chronic
obstructive pulmonary disease (COPD). Eur Respir J
1995; 8: 1398–1420.
10. Butland RJA, Pang J, Gross ER, Woodcock AA,
Geddes DM. Two, six and 12 minute walking tests
in respiratory disease. Br J Dis Chest 1982; 284:
1607–1608.
11. Quanjer PhH. Standardized lung function testing. Eur
Respir J 1993; 16 (Suppl. 6): 5–100.
12. Mahler DA, Weinberg DM, Wells CK, Feinstein AR.
The measurement of dyspnea: contents, interobserver
agreement, and physiologic correlates of two new
clinical indexes. Chest 1984; 85: 751–758.
13. Borg G. Psychophysical basis of perceived exertion.
Med Sci Sports Ex 1982; 14: 377–381.
HOME-BASED EXERCISE TRAINING IN SEVERE COPD 119114. Guyatt GH, Berman LB, Townsend M, Pugsley SO,
Chambers LW. A measure of quality of life for
clinical trials in chronic lung disease. Thorax 1987;
42: 773–778.
15. Kirsten D, Wegner R, Jo¨rres RA, Magnussen H.
Effects of theophylline therapy withdrawl in severe
chronic obstructive pulmonary disease. Chest 1993;
104: 1101–1107.
16. Beaumont A, Crockroft A, Guz A. A self paced
treadmill walking test for breathless patients. Thorax
1987; 42: 773–778.
17. Bergmeyer HU, Noll F. Methode der enzymatischen
Analyse. Weinheim: Verlag Chemie, 3rd edn, Vol. II.
1974; 1521.
18. Morgan MDL. Experience of using the CRQ (Chronic
Respiratory Questionnaire). Respir Med 1991; 85
(Suppl. B): 23–24.
19. Bendstrup KE, Ingemann Jensen J, Holm S, Bengtsson
B. Out-patient rehabilitation improves activities of
daily living, quality of life and exercise tolerance in
chronic obstructive pulmonary disease. Eur Respir J
1997; 10: 2801–2806.
20. Vale F, Reardon JZ, ZuWallack RL. The long-term
benefits of outpatient pulmonary rehabilitation on exercise
endurance and quality of life. Chest 1993; 103: 42–45.
21. Stevens D, Elpern E, Sharma K, Szidon P, Ankin M,
Kesten S. Comparison of hallway and six-minute
walk tests. Am J Respir Crit Care Med 1999; 160:
1540–1543.
22. Mohsenifar Z, Dorak D, Brown HV, Koerner SK.
Sensitive Indices of improvement in a pulmonary
rehabilitation program. Chest 1983; 83: 189–192.
23. Casaburi R, Patessio A, Iolio F, Zanaboni S, Donner
CF, Wassermann K. Reductions in exercise lactic
acidosis and ventilation as a result of exercise training
in patients with obstructive lung disease. Am Rev Respir
Dis 1991; 143: 9–18.
24. Maltais F, LeBlanc P, Jobin J, Be´rube´ C, Bruneau J,
Carrier L, Breton M-J, Falardeau G, Belleau R.
Intensity of training and physiologic adaptation in
patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1997; 155: 555–561.25. Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul
SM, Stulbarg MS. Exercise training decreases dyspnea
and the distress and anxiety associated with it. Chest
1996; 110: 1526–1535.
26. Strijbos JH, Postma DS, Van Altena R, Gimeno F,
Koeter GH. A comparison between outpatient hospi-
tal-based pulmonary rehabilitation program and a
home-care pulmonary rehabilitation program in pa-
tients with COPD. A follow-up of 18 months. Chest
1996; 109: 366–372.
27. O’Donnell DE, McGuire M, Samis L, Webb KA. The
impact of exercise reconditioning on breathlessness in
severe chronic airflow limitation. Am J Respir Crit Care
Med 1995; 152: 2005–2013.
28. Haas F, Slazar-Schicchi J, Axen K. Desensitization to
dyspnea in chronic obstructive pulmonary disease. In:
Casaburi R, Petty TL, eds. Principles and Practice of
Pulmonary Rehabilitation. Philadelphia: WB Saunders,
1993; 241–251.
29. O’Donnell DE, Webb KA. Exertional breathlessness in
patients with chronic airflow limitation. The role of lung
hyperinflation. Am Rev Respir Dis 1993; 148: 1351–1357.
30. Wegner RE, Jo¨rres RA, Kirsten DK, Magnussen H.
Factor analysis of exercise capacity, dyspnoea ratings
and lung function in patients with severe COPD. Eur
Respir J 1994; 7: 725–729.
31. Reardon J, Awad E, Normandin E, Vale F, Clark B,
Zuwallack RL. The effect of comprehensive outpatient
pulmonary rehabilitation on dyspnea. Chest 1994; 105:
1046–1052.
32. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ,
Goldstein RS. Metaanalysis of respiratory rehabilita-
tion in chronic obstructive pulmonary disease. Lancet
1996; 348: 1115–1119.
33. Goldstein RS, Gort EH, Stubbing D, Avendano MA,
Guyatt GH. Randomised trial of respiratory rehabili-
tation. Lancet 1994; 344: 1394–1397.
34. Casaburi R, Porszasz J, Burns MR, Carithers ER,
Chang RSY, Cooper CB. Physiologic benefits of
exercise training in rehabilitation of patients with
severe chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1997; 15: 1541–1551.
